Biotechnology Industry Takes Action to Diversify Leadership

Editorial & Advertiser Disclosure Global Banking And Finance Review is an independent publisher which offers News, information, Analysis, Opinion, Press Releases, Reviews, Research reports covering various economies, industries, products, services and companies. The content available on globalbankingandfinance.com is sourced by a mixture of different methods which is not limited to content produced and supplied by various staff writers, journalists, freelancers, individuals, organizations, companies, PR agencies Sponsored Posts etc. The information available on this website is purely for educational and informational purposes only. We cannot guarantee the accuracy or applicability of any of the information provided at globalbankingandfinance.com with respect to your individual or personal circumstances. Please seek professional advice from a qualified professional before making any financial decisions. Globalbankingandfinance.com also links to various third party websites and we cannot guarantee the accuracy or applicability of the information provided by third party websites. Links from various articles on our site to third party websites are a mixture of non-sponsored links and sponsored links. Only a very small fraction of the links which point to external websites are affiliate links. Some of the links which you may click on our website may link to various products and services from our partners who may compensate us if you buy a service or product or fill a form or install an app. This will not incur additional cost to you. A very few articles on our website are sponsored posts or paid advertorials. These are marked as sponsored posts at the bottom of each post. For avoidance of any doubts and to make it easier for you to differentiate sponsored or non-sponsored articles or links, you may consider all articles on our site or all links to external websites as sponsored . Please note that some of the services or products which we talk about carry a high level of risk and may not be suitable for everyone. These may be complex services or products and we request the readers to consider this purely from an educational standpoint. The information provided on this website is general in nature. Global Banking & Finance Review expressly disclaims any liability without any limitation which may arise directly or indirectly from the use of such information.

The Biotechnology Innovation Organization (BIO) announced today the Right Mix Matters campaign to increase diversity and inclusion in the biotech industry. Following on its previously announced goals to increase gender, racial, ethnic and LGBTQ representation on biotech company boards, in C-suites and in functional leadership positions, BIO is providing specific tools to accelerate diversity and thereby advance an even more globally competitive industry.

As the largest trade association representing the full range of biotech companies, BIO is launching two new solutions and tangible resources:

  • The new BIO Boardlist is an online portal of curated talent that connects highly qualified diverse leaders with opportunities to serve on private and public company boards.
  • The BIO Diversity & Inclusion (D&I) Toolkit is a set of practical tools for developing programs, procedures and best practices to build a diverse workforce.

Our industry is stronger than ever before and there is a collective sense of excitement about the future of biotechnology, said Helen Torley, CEO of Halozyme and Chair of BIOs board-level Workforce Development, Diversity, and Inclusion Committee. Continued progress requires an unprecedented level of innovation and problem solvingand this is best achieved by tapping into multiple and diverse perspectives and experiences. The new tools address specific barriers biotech leaders tell us they face today in building diverse and inclusive teams and boards and will, I believe, lead to improved development and increased visibility of talented, diverse leaders.

According to the 2018 Why Diversity Matters report conducted by McKinsey & Company, companies in the top 25% for gender diversity and top 35% for racial diversity are more likely to have higher financial returns than less diverse companies.

The BIO Boardlist database provides detailed profiles of talented, board-eligible, diverse individuals with extensive experience in the biotech industry. CEOs and/or board members can nominate board-ready diverse candidates for the BIO Boardlist. Once vetted and approved, candidates become part of the BIO Boardlist and can be discovered by CEOs and board members through a search feature.

All leaders, employees and human resources departments of biotech companies around the country will have access to proven tools through the D&I Toolkit which can assist with identifying and developing diverse talent. This includes the top resources from successful programs from member companies.

BIO members know that diverse teams are critical to the long-term success and innovation of any organization, said Jim Greenwood, president and CEO of BIO. Our members are looking for tools and resources to ensure diversity, from the ground floor to the C-suite and board, and were happy to unite biotechnology under one vision. Our tools are designed to supplement competitive teams interested in remaining at the forefront of our industry.

The Right Mix Matters campaign is an initiative of BIOs Workforce Development, Diversity, & Inclusion Committee. Chaired by Helen Torley, the committee is headed at the BIO staff level by Joanne Duncan, President of BIOs Membership and Business Operations Division. Learn about the campaign at RightMixMatters.org.

About BIO

BIO is the world’s largest trade association representing biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the worlds largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world. BIOtechNOW is BIO’s blog chronicling innovations transforming our world and the BIO Newsletter is the organizations bi-weekly email newsletter. Subscribe to the BIO Newsletter.

Upcoming BIO Events

           

BIO International Convention June 3-6, 2019 Philadelphia, PA

       

BIO World Congress July 8-11, 2019 Des Moines, Iowa

       

Theresa Brady
202.997.9034
Web:
www.bio.org
Blog:
www.biotech-now.org
Twitter:
@IAmBiotech